These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20853060)

  • 1. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.
    Verbanac KM; Min CJ; Mannie AE; Lu J; O'Brien KF; Rosman M; Tafra L;
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():368-77. PubMed ID: 20853060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study.
    Fisher CS; Cole DJ; Mitas M; Garrett-Meyer E; Metcalf JS; Gillanders WE; Mikhitarian K; Urist MM; Mann GB; Doherty G; Herrmann VM; Hill AD; Eremin O; El-Sheemy M; Orr RK; Valle AA; Henderson MA; Dewitty RL; Sugg SL; Frykberg E; Yeh K; Bell RM; Baker MK
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():312-20. PubMed ID: 20853052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
    Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
    Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
    Ouellette RJ; Richard D; Maïcas E
    Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of interleukin-10 in sentinel lymph node with breast cancer.
    Woo SU; Bae JW; Yang JH; Kim JH; Nam SJ; Shin YK
    Ann Surg Oncol; 2007 Nov; 14(11):3268-73. PubMed ID: 17762971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of breast sentinel lymph nodes.
    Blumencranz PW; Pieretti M; Allen KG; Blumencranz LE
    Surg Oncol Clin N Am; 2011 Jul; 20(3):467-85, viii. PubMed ID: 21640916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.
    Viale G; Dell'Orto P; Biasi MO; Stufano V; De Brito Lima LN; Paganelli G; Maisonneuve P; Vargo JM; Green G; Cao W; Swijter A; Mazzarol G
    Ann Surg; 2008 Jan; 247(1):136-42. PubMed ID: 18156933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA.
    Dell'Orto P; Biasi MO; Del Curto B; Zurrida S; Galimberti V; Viale G
    Breast Cancer Res Treat; 2006 Jul; 98(2):185-90. PubMed ID: 16538532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
    Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
    Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis.
    Yuan Z; Sanders AJ; Ye L; Wang Y; Jiang WG
    Anticancer Res; 2011 Jan; 31(1):303-10. PubMed ID: 21273615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
    Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel diagnostic procedure for determining metastasis to sentinel lymph nodes in breast cancer using a semi-dry dot-blot method.
    Otsubo R; Oikawa M; Hirakawa H; Shibata K; Abe K; Hayashi T; Kinoshita N; Shigematsu K; Hatachi T; Yano H; Matsumoto M; Takagi K; Tsuchiya T; Tomoshige K; Nakashima M; Taniguchi H; Omagari T; Itoyanagi N; Nagayasu T
    Int J Cancer; 2014 Feb; 134(4):905-12. PubMed ID: 23913465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
    Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
    Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.